MAY 29, 2018 07:30 AM PDT

Early Research Makes Connection Between Liver Tumor Growth Control and Gut Microbiota

As researchers learn more about the gut microbiome, they have focused attention on the interactions between the individual bacteria, the body, and immunity.  Researchers recently published work in Science sharing findings of a connection between the gut microbiome and liver tumor growth.

The gut microbiome, or gut microbiota, describes the diverse environment of microorganisms in the human and animal digestive tract.  Many studies have looked at the connections between the gut microbiome and human health and disease.  Its role is critical for human metabolism and affects nutrition, physiology and immune function.  It is widely accepted that there are hundreds of different species of bacteria that can make up an individual’s gut microbiota; in fact, at least a third are shared amongst a majority of people with the other two thirds being unique to each individual.  Our individual gut microbiome is like a fingerprint on the inside.

The murine study published in Science focused on the effects of antibiotics and gut microbiota in the presence of liver tumors.  The group used three different liver cancer types and reduced gastrointestinal bacteria with a combination of antibiotics.  The researchers found that by treating mice with liver tumors with antibiotics, they decreased particular bacteria and in turn, changed the make-up of immune cells in the liver.  The decreased number of bacteria induced an increase in natural killer T-cells which actually shrunk the liver tumors and acted as tumor suppressors.  In exploring this finding, the researchers determined that the accumulation of natural killer cells in the liver occurred due to increased expression of CXCL16, a protein found on the lining cells of liver capillaries.  In examining the role of CXCL16, the protein expression patterns were regulated by bile acids.  Increasing bile acids in mice changed the number of natural killer cells found in the liver and, therefore, could decrease the number of tumors in the liver.

The last connection made in this publication was that one specific bacterial species in the mouse microbiome controls metabolism of bile acids.  Clostridium scindens moderates CXCL16 expression, affects natural killer cell presence, and tumor cell growth within the environment of the liver.

The authors recognize that these results are just the beginning but lay the groundwork for future discoveries connecting the gut microbiome to key processes in our bodies that are, as of yet, unknown.

Sources: Science, National Cancer Institute, Gut Microbiota for Health,

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
OCT 19, 2019
Cell & Molecular Biology
OCT 19, 2019
Insight Into a DNA Damage Sensor That Orchestrates Repair
Simple cell functions like division or metabolism can lead to DNA damage, which can also occur because of normal exposure to the sun or noxious agents....
OCT 19, 2019
Cancer
OCT 19, 2019
How cancer tricks our immune systems
Research published yesterday in Nature details the finding of a new “Don’t eat me” signal that cancers use to hide from the body’s ...
OCT 19, 2019
Cancer
OCT 19, 2019
Understanding TP53's role in cancer
New research published in the journal Cell Reports sheds light on the role of the TP53 gene in preventing the spread of cancer. The TP53 gene codes tumor p...
OCT 19, 2019
Cancer
OCT 19, 2019
Treating dogs with human breast cancer drugs
Did you know that dogs get lung cancer? New research published recently in the journal Clinical Cancer Research shows how dogs with cancer are benefiting f...
OCT 19, 2019
Cardiology
OCT 19, 2019
Childhood Cancer Survivors Prone to Cardiac Events
A new study published in the American Heart Association's journal Circulation explores the relationship between childhood cancer, metabolic conditions ...
OCT 19, 2019
Cell & Molecular Biology
OCT 19, 2019
New Type of CAR T-Cell Therapy Headed for Clinical Trials
Scientists have been trying to use the immune system in cancer patients' bodies to fight cancer....
Loading Comments...